| Cancer Genet. Cytogenet
| [0001]
|
| Int. J. Oncol.
| [0001]
|
| Am. J. Pathol.
| [0001]
|
| Genes Chromosomes Cancer
| [0001]
|
| Am. J. Hum. Genet.
| [0001]
|
| Int.J.Oncol.
| [0001]
|
| Nat.Genet.
| [0001]
|
| Nat. Genet.
| [0002]
|
| Science
| [0003]
|
| J. Pathology
| [0003]
|
| Representational oligonucleotide microarray analysis: a high-resolution method to detect genome copy number variation
| [0004]
|
| Med. Hypotheses.
| [0006]
|
| Science
| [0049]
|
| Methods Enzymol.
| [0049]
|
| Mamm. Genome.
| [0050]
|
| Genome Res.
| [0050]
|
| Am. J. Med. Genet. A.
| [0051]
|
| High-resolution mapping of molecular events associated with immortalization, transformation, and progression to breast cancer in the MCF10 model.
| [0052]
|
| Clin. Genet.
| [0052]
|
| Curr. Op. Chem. Biol.
| [0053]
|
| Mass Spec. Rev.
| [0053]
|
| Nature
| [0053]
|
| Specific expression of the annexin VIII gene in acute promyelocytic leukemia
| [0176]
|
| Y4 receptor knockout rescues fertility in ob/ob mice
| [0176]
|
| Identification of high risk breast-cancer patients by gene expression profiling
| [0178]
|
| Prognostic relevance of gene amplifications and coamplifications in breast cancer
| [0178]
|
| Profiling breast cancer by array CGH
| [0178]
|
| The genetics and genomics of cancer
| [0178]
|
| Association between RB-1 gene alterations and factors of favourable prognosis in human breast cancer, without effect on survival
| [0178]
|
| Analysis of different deleted regions in chromosome 11 and their interrelations in early- and late-onset breast tumors: association with cyclin D1 amplification and survival
| [0178]
|
| Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to early amplicons
| [0178]
|
| A versatile statistical analysis algorithm to detect genome copy number variation
| [0178]
|
| Cancer chromosomes in crisis
| [0178]
|
| Good Old'' clinical markers have similar power in breast cancer prognosis as microarray gene expression profilers
| [0178]
|
| Near tetraploid prostate carcinoma. Methodologic and prognostic aspects
| [0178]
|
| Ploidy level determinations in high-grade and low-grade malignant variants of prostatic carcinoma
| [0178]
|
| A 1 Mb minimal amplicon at 8p11-12 in breast cancer identifies new candidate oncogenes
| [0178]
|
| Chromosomal breakage-fusion-bridge events cause genetic intratumor heterogeneity
| [0178]
|
| A role for common fragile site induction in amplification of human oncogenes
| [0178]
|
| HER-2/neu and topoisomerase IIalpha in breast cancer
| [0178]
|
| Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization
| [0178]
|
| Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors
| [0178]
|
| Detection of retinoblastoma gene copy number in metaphase chromosomes and interphase nuclei by fluorescence in situ hybridization
| [0178]
|
| ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization
| [0178]
|
| Retrospective analysis of topoisomerase IIa amplifications and deletions as predictive markers in primary breast cancer patients randomly assigned to cyclophosphamide, methotrexate, and fluorouracil or cyclophosphamide, epirubicin, and fluorouracil: Danish Breast Cancer Cooperative Group
| [0178]
|
| Improved grading of breast adenocarcinomas based on genomic instability
| [0178]
|
| Whole genome analysis of genetic alterations in small DNA samples using hyperbranched strand displacement amplification and array-CGH
| [0178]
|
| Array comparative genomic hybridization analysis of genomic alterations in breast cancer subtypes
| [0178]
|
| Representational oligonucleotide microarray analysis: a high-resolution method to detect genome copy number variation
| [0178]
|
| Total loss of MHC class I is an independent indicator of good prognosis in breast cancer
| [0178]
|
| The production of homozygous deficient tissues with mutant characteristics by means of the aberrant mitotic behavior of ring-shaped chromosomes
| [0178]
|
| The stability of broken ends of chromosomes in Zea Mays
| [0178]
|
| HER2 as a prognostic factor in breast cancer
| [0178]
|
| PROBER : oligonucleotide FISH probe design software
| [0178]
|
| Candidate genes in breast cancer revealed by microarray-based comparative genomic hybridization of archived tissue
| [0178]
|
| Circular binary segmentation for the analysis of array-based DNA copy number data
| [0178]
|
| Cyclin D1, EMS1 and 11q13 amplification in breast cancer
| [0178]
|
| A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
| [0178]
|
| Molecular portraits of human breast tumours
| [0178]
|
| Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors
| [0178]
|
| Comparative genomic hybridization of formalin-fixed, paraffin-enbedded breast tumors reveals different patterns of chromosomal gains and losses in fibroadenomas and diploid and aneuploid carcinomas
| [0178]
|
| Tumor cytogenetics revisited: comparative genomic hybridization and spectral karyotyping
| [0178]
|
| Large-scale copy number polymorphism in the human genome
| [0178]
|
| A consistent pattern of RIN1 rearrangements in oral squamous cell carcinoma cell lines supports a breakage-fusion-bridge cycle model for 11q13 amplification
| [0178]
|
| Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer
| [0178]
|
| Gene expression patterns of carcinomas distinguish tumor subclasses with clinical implications
| [0178]
|
| Breast cancer classification and prognosis based on gene expression profiles from a population-based study
| [0178]
|
| Widespread and nonrandom distribution of DNA palindromes in cancer cells provides a structural platform for subsequent gene amplification
| [0178]
|
| Molecular cytogenetics of primary breast cancer by CGH
| [0178]
|
| Gene expression profiling predicts clinical outcome of breast cancer
| [0178]
|
| Amplification of the neu (c-erbB-2) oncogene in human mammmary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene
| [0178]
|
| Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer
| [0178]
|